Methods: Thirty - seven patients with T3, T4, no metastasis rectal cancer were treated with radiotherapy (45 Gy/25 fractions) and concomitant Capecitabine (825 mg / m2 bid on each day of the radiotherapy period) at Hue Central Hospital between February 2019 and July 2021.